Gene Delivery Technologies - Global Market Outlook (2020-2028)

   |      |      |  

Gene Delivery Technologies - Global Market Outlook (2020-2028)

Global Gene Delivery Technologies Market is accounted for $2.60 billion in 2020 and is expected to reach $9.19 billion by 2028 growing at a CAGR of 17.1% during the forecast period. Advantages like briefness and nontoxicity nature, technological advancements in viral vectors, growing pipeline of advanced therapies, are the factors driving the market growth. However, several clinical challenges associated with viral systems have spurred the usage of chemical methods which may restrain the growth of the market.

Gene delivery is the process of introducing foreign gene delivery, such as DNA or RNA, into host cells, the technologies used to implement the gene delivery are gene delivery technologies. Gene delivery technology is widely applied for various diseases treatment caused from bacterial infections, exterior chemical toxins, viral invasions, malignant tumours and endogenous genetic defects. The advent of cell and gene therapies played a major role in reshaping the entire pharmaceutical ecosystem by transforming the treatment of genetic and intractable diseases.

Based on the application, the gene therapy segment is going to have lucrative growth during the forecast period due to the growing acceptance of gene-based therapies and the consequent increase in the number of clinical research initiatives have fuelled the revenue generation in this segment. Increasing acceptance of gene therapy products worldwide has also accelerated the segment growth.

By geography, North America is going to have high growth during the forecast period due to the substantial number of clinical trials are underway to assess the efficacy and safety of gene therapies as a viable treatment for incurable diseases such as cancer, genetic disorders, HIV in the U.S., Many innovative projects covering viral vector-based gene therapy trials for rare conditions are being introduced in North America. These factors increase the demand of the North America region in the market for gene delivery technologies.

Some of the key players profiled in the Gene Delivery Technologies Market include Bio-Rad Laboratories, Inc., Catalent Inc., OriGene Technologies, Inc., Oxford Biomedica,  Promega Corporation, QIAGEN, SignaGen Laboratories, Sirion-Biotech GmbH, System Biosciences llc, Takara Bio Inc., Thermo Fisher Scientific, Inc., Vectalys and Horizon Discovery Group Plc.

Methods Covered:
• Ex-Vivo
• In-Vivo
• In Vitro

Applications Covered:
• Gene Therapy
• Cell Therapy
• Vaccines
• Research   

Modes Covered:
• Biological
• Chemical
• Physical  

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

1 Executive Summary        
         
2 Preface        
 2.1 Abstract       
 2.2 Stake Holders       
 2.3 Research Scope        
 2.4 Research Methodology       
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources      
  2.5.2 Secondary Research Sources      
  2.5.3 Assumptions      
         
3 Market Trend Analysis        
 3.1 Introduction       
 3.2 Drivers       
 3.3 Restraints       
 3.4 Opportunities       
 3.5 Threats       
 3.6 Application Analysis       
 3.7 Emerging Markets       
 3.8 Impact of Covid-19       
         
4 Porters Five Force Analysis        
 4.1 Bargaining power of suppliers       
 4.2 Bargaining power of buyers       
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry       
         
5 Global Gene Delivery Technologies Market, By Method        
 5.1 Introduction       
 5.2 Ex-Vivo       
 5.3 In-Vivo       
 5.4 In Vitro       
         
6 Global Gene Delivery Technologies Market, By Application        
 6.1 Introduction       
 6.2 Gene Therapy       
 6.3 Cell Therapy       
 6.4 Vaccines       
 6.5 Research       
         
7 Global Gene Delivery Technologies Market, By Mode        
 7.1 Introduction       
 7.2 Biological        
  7.2.1 Adenoassociated Virus (AAV)      
  7.2.2 Lentivirus      
  7.2.3 Retrovirus      
  7.2.4 Adenovirus      
  7.2.5 Non-Viral      
 7.3 Chemical       
 7.4 Physical       
         
8 Global Gene Delivery Technologies Market, By Geography        
 8.1 Introduction       
 8.2 North America       
  8.2.1 US      
  8.2.2 Canada      
  8.2.3 Mexico      
 8.3 Europe       
  8.3.1 Germany      
  8.3.2 UK      
  8.3.3 Italy      
  8.3.4 France      
  8.3.5 Spain      
  8.3.6 Rest of Europe      
 8.4 Asia Pacific       
  8.4.1 Japan      
  8.4.2 China      
  8.4.3 India      
  8.4.4 Australia      
  8.4.5 New Zealand      
  8.4.6 South Korea      
  8.4.7 Rest of Asia Pacific      
 8.5 South America        
  8.5.1 Argentina      
  8.5.2 Brazil      
  8.5.3 Chile      
  8.5.4 Rest of South America      
 8.6 Middle East & Africa       
  8.6.1 Saudi Arabia      
  8.6.2 UAE      
  8.6.3 Qatar      
  8.6.4 South Africa      
  8.6.5 Rest of Middle East & Africa      
         
9 Key Developments        
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures       
 9.2 Acquisitions & Mergers       
 9.3 New Product Launch       
 9.4 Expansions       
 9.5 Other Key Strategies        
         
10 Company Profiling        
 10.1 Bio-Rad Laboratories, Inc.       
 10.2 Catalent Inc.       
 10.3 OriGene Technologies, Inc.       
 10.4 Oxford Biomedica       
 10.5 Promega Corporation       
 10.6 QIAGEN       
 10.7 SignaGen Laboratories       
 10.8 Sirion-Biotech GmbH       
 10.9 System Biosciences llc       
 10.10 Takara Bio Inc.       
 10.11 Thermo Fisher Scientific, Inc.       
 10.12 Vectalys       
 10.13 Horizon Discovery Group Plc.       

 

Gene Delivery Technologies - Global Market Outlook (2020-2028)

List of Tables         
1 Global Gene Delivery Technologies Market Outlook, By Region (2019-2028) (US $MN)         
2 Global Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
3 Global Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
4 Global Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
5 Global Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)        
6 Global Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
7 Global Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)        
8 Global Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
9 Global Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
10 Global Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
11 Global Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
12 Global Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)        
13 Global Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
14 Global Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
15 Global Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
16 Global Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
17 Global Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
18 Global Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
19 Global Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        
20 North America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)         
21 North America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
22 North America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
23 North America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
24 North America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)        
25 North America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
26 North America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)         
27 North America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
28 North America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
29 North America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
30 North America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
31 North America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)         
32 North America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
33 North America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
34 North America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
35 North America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
36 North America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
37 North America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
38 North America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        
39 Europe Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)         
40 Europe Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
41 Europe Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
42 Europe Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
43 Europe Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)        
44 Europe Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
45 Europe Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)        
46 Europe Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
47 Europe Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
48 Europe Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
49 Europe Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
50 Europe Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)        
51 Europe Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
52 Europe Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
53 Europe Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
54 Europe Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
55 Europe Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
56 Europe Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
57 Europe Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        
58 Asia Pacific Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)         
59 Asia Pacific Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
60 Asia Pacific Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
61 Asia Pacific Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
62 Asia Pacific Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)         
63 Asia Pacific Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
64 Asia Pacific Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)        
65 Asia Pacific Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
66 Asia Pacific Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
67 Asia Pacific Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
68 Asia Pacific Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
69 Asia Pacific Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)        
70 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
71 Asia Pacific Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
72 Asia Pacific Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
73 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
74 Asia Pacific Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
75 Asia Pacific Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
76 Asia Pacific Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        
77 South America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)         
78 South America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
79 South America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
80 South America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
81 South America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)        
82 South America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
83 South America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)        
84 South America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
85 South America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
86 South America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
87 South America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
88 South America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)        
89 South America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
90 South America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
91 South America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
92 South America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
93 South America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
94 South America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
95 South America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        
96 Middle East & Africa Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)         
97 Middle East & Africa Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)        
98 Middle East & Africa Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)        
99 Middle East & Africa Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)        
100 Middle East & Africa Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)        
101 Middle East & Africa Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)        
102 Middle East & Africa Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)        
103 Middle East & Africa Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)        
104 Middle East & Africa Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)        
105 Middle East & Africa Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)        
106 Middle East & Africa Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)        
107 Middle East & Africa Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)        
108 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)        
109 Middle East & Africa Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)        
110 Middle East & Africa Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)        
111 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)        
112 Middle East & Africa Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)        
113 Middle East & Africa Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)        
114 Middle East & Africa Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)        

 

.